Liposomal bupivacaine during subcutaneous implantable cardioverter defibrillator implantation for pa...
Liposomal bupivacaine during subcutaneous implantable cardioverter defibrillator implantation for pain management
About this item
Full title
Author / Creator
Publisher
United States: Wiley Subscription Services, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Wiley Subscription Services, Inc
Subjects
More information
Scope and Contents
Contents
Background
The subcutaneous implantable cardioverter‐defibrillator (S‐ICD) has a larger generator and its implantation involves more dissection and tunneling compared to traditional transvenous defibrillator system. Liposomal bupivacaine, an extended‐release bupivacaine with 72 h of duration has been used for postoperative pain management in pat...
Alternative Titles
Full title
Liposomal bupivacaine during subcutaneous implantable cardioverter defibrillator implantation for pain management
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2481124887
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2481124887
Other Identifiers
ISSN
0147-8389
E-ISSN
1540-8159
DOI
10.1111/pace.14175
